BioSpace News Archive

Vericool, the inventors of the world’s first recyclable/biodegradable cooler, have developed a worldwide sustainable thermal solution for shipping COVID-19 vaccines that is both recyclable and compostable.

Aspen Surgical Products, Inc. (“Aspen”), a leader in surgical disposable products, announced the acquisition of Protek Medical Products, Inc. (“Protek” or the “Company”). Based in Coralville, IA, Protek is a leading global manufacturer of single-use ultrasonic probe covers and needle guides used in tissue biopsies, fluid aspiration

Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced a $50 million expansion of its sterile fill/finish manufacturing facilities located in Bloomington, Ind

Havn Life Sciences Inc. is pleased to announce that 10,927,856 common share purchase warrants have been exercised, resulting in proceeds to the Company of $5.46 million.

Kadmon Holdings, Inc. announced that the Company will host a virtual key opinion leader event on Sunday, December 6, 2020 at 11:15 a.m. PT at the 62nd American Society of Hematology Annual Meeting.

Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that Julian Adams, Chief Executive Officer of Gamida Cell, will present at two virtual conferences in December

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company’s Chief Executive Officer and President, will present at the following upcoming investor conference

Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that the Company will participate at the Diamond Equity Research Emerging Growth Invitational taking place virtually on December 1, 2020

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that Amit D. Munshi, the Company’s President and Chief Executive Officer, is scheduled to participate in a virtual fireside chat at the 3rd Annual Evercore ISI HealthCONx Conference on Tuesday, December 1, at 4:20 PM ET.

Award will help to fund planned Phase Ib/IIa study of inhaled murepavadin, a novel class antibiotic for the treatment of chronic Pseudomonas aeruginosa infections in cystic fibrosis